192 related articles for article (PubMed ID: 9668368)
1. Antiglycosphingolipid immune responses in neurology. The Vienna experience with isotypes, subclasses, and disease.
Gatterbauer B; Neisser A; Bernheimer H; Schwerer B
Ann N Y Acad Sci; 1998 Jun; 845():353-62. PubMed ID: 9668368
[TBL] [Abstract][Full Text] [Related]
2. Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.
Schwerer B; Neisser A; Bernheimer H
Infect Immun; 1999 May; 67(5):2414-20. PubMed ID: 10225903
[TBL] [Abstract][Full Text] [Related]
3. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
4. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
5. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
Koga M; Yuki N; Hirata K
J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
[TBL] [Abstract][Full Text] [Related]
6. IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses.
Ogino M; Orazio N; Latov N
J Neuroimmunol; 1995 Apr; 58(1):77-80. PubMed ID: 7730449
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
8. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
Yuki N; Miyatake T
Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
[TBL] [Abstract][Full Text] [Related]
10. The role of antiglycolipid antibodies in neurological disorders.
Fredman P
Ann N Y Acad Sci; 1998 Jun; 845():341-52. PubMed ID: 9668367
[TBL] [Abstract][Full Text] [Related]
11. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
14. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
Gregson NA; Rees JH; Hughes RA
J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
[TBL] [Abstract][Full Text] [Related]
16. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome.
von Wulffen H; Hartard C; Scharein E
J Infect Dis; 1994 Oct; 170(4):828-33. PubMed ID: 7930724
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA
J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
19. Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barré syndrome.
Jacobs BC; Meulstee J; van Doorn PA; van der Meché FG
Muscle Nerve; 1997 Apr; 20(4):446-52. PubMed ID: 9121502
[TBL] [Abstract][Full Text] [Related]
20. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome.
Yuki N; Ichihashi Y; Taki T
J Neuroimmunol; 1995 Jul; 60(1-2):161-4. PubMed ID: 7543907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
